[1]
Pérez-Ruiz, L., Rodríguez-Mendoza, M., Soto-Molina, H., Galán-ÁlvarezY., Viada-González, C. and Collazo-Herrera, M. 2020. Nimotuzumab (CIMAher®) in Cuban patients with head and neck cancer stage III/IV: Budget impact analysis. VacciMonitor. 29, 1 (Jan. 2020), 14-21.